The impact of the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) to address shortages of human and veterinary medicines across Europe

View Full Paper

Ask AI

Bookmark

Medicines shortages pose significant challenges to patient care, impacting both human and veterinary medicines across Europe.
The article discusses EMA's taskforce role in addressing these shortages, particularly since 2016, leading to critical regulatory initiatives.
Regulation (EU) 2022/123 reinforces EMA's mandate in managing medicines shortages, aiming for improved crisis preparedness.
Future strategies for preventing shortages will align with the proposed Critical Medicines Act and revised pharmaceutical legislation.

Discussion

No takes yet. Share an insight, caveat, or question.

Reflection on EMA and HMA's role in addressing medicines shortages, highlighting regulatory frameworks and strategic initiatives.

Abed et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark